Using Curcumin Nano-Lipid Particles in a Therapeutic Approach
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Curcumin (Curcuma longa) is a plant-based polyphenol known to have several medicinal properties.
Although several promising effects of using curcumin in clinical trials have been observed, its overall
medicinal qualities are still limited due to low bioavailability. In order to increase the bioavailability, we
are embedding curcumin within Nano-Lipid Particles (both curcumin telodendrimer discs and curcumin
tNLPs).
Telodendrimer nanolipoprotein particles (tNLPs) are discoidal self-assemblies containing lipids and
apolipoproteins which can be used as a vehicle to carry proteins and other small molecules to the cell.
Telodendrimer NLPs have been used to increase the bioavailability of drugs, and provide an ideal platform
to increase curcumin bioavailability. The generation of tNLPs can be accomplished using several methods;
such as cell-free assembly and in-vitro assembly.
Curcumin telodendrimer discs (curcumin telo-discs) are a nano-lipid mixture of lipids, curcumin, and
telodendrimer that acts as the basis for the curcumin tNLP reaction. Using the curcumin telo-disc as the
starting additive, we demonstrate that we can purify properly formed curcumin tNLPs via affinity columns
and size-exclusion chromatography (SEC). Here, we show that with two separate methods: a cell-free
expressed method and in-vitro assembly, we can demonstrate that curcumin can be successfully
incorporated and purified within the tNLP particle in a single reaction tube.

Introduction

Nano-lipid particles act as a platform for delivering and increasing the bioavailability of drugs as well
as other small molecules into the cell. Both telodendrimer discs (telo-discs) and telodendrimer
nanolipoprotein particles (tNLPs) have the potential to increase cellular uptake of the “cargo” with which
they hold. By loading the curcumin molecule onto telo-discs and tNLPs, we provide a novel platform to
increase curcumin bioavailability. Upon curcumin loading, we named these nano-lipid particles “curcumin
telo-discs” and “curcumin tNLPs”, respectively.
We illustrate three main methods we developed to form curcumin nano-lipid particles. Method 1
outlines the curcumin telo-disc assembly. In brief, lipid, telodendrimer, and curcumin are mixed and
sonicated in an Eppendorf tube. After sonication, curcumin telo-discs have been formed.
Method 2 illustrates the cell-free production of curcumin tNLPs. In this method, we combine
curcumin, lipids, telodendrimer and ApoA1 plasmid to the reaction tube. Upon overnight incubation and
shaking, curcumin tNLPs form spontaneously.
Method 3 demonstrates an in vitro production of curcumin tNLPs. Using the best-condition from the
cell-free assembly, we begin this procedure with curcumin telo-disc formation. After curcumin telo-disc
has been formed, we add in ApoA1 protein and incubate overnight to form spontaneous curcumin tNLPs.
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There are two variations to the procedure above:
1) Sonicate for 30 minutes before overnight incubation.
2) Sonicate for 30 minutes before overnight incubation, and add more curcumin the next morning.
This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.²

E6

E7

E4

E5

E6

E7

0.01

0.02

A.

SEC– 280nm

Curcumin-tNLP

SEC– 430nm
Curcumin

Sonicated for 30 minutes

B.

SEC– 280nm
Curcumin-tNLP

SEC– 430nm
Curcumin

Sonicated for 30 minutes, and added more curcumin

We used cell-free
approaches for making
nanoparticles (Methods
1 & 2). The standard
curve created uses the
absorption of curcumin
to determine its soluble
concentration. To create
the standard curve, we
had to make two fold
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soluble nanoparticles
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The pictures represent the
elutions from affinity purification
using column chromatography to
purify the nanoparticles. A)
Illustrates the color of the
elutions containing curcumin in
visible light, which show a yellow
color indicating the presence of
curcumin. B) Illustrates the color
of the elutions containing
curcumin in UV light, which
indicates the solubility of the
curcumin associated with the
nanoparticle.
We pooled elutions that have
intense yellow coloring,
indicating increased curcumin
concentrations, for further
analysis.
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We also used traditional in-vitro approaches
for making nanoparticles (Method 3). For this
reaction we wanted to confirm that the
curcumin and the apolipoprotein (ApoA1) coelute within the same fractions using size
exclusion chromatography, which separates
large particles from small particles. The
particles contain protein that can be measured
at 280 nm. In addition, we can obtain a
spectral chromatograph of the soluble
curcumin at 430 nm. In both sets of graphs we
are looking to make sure that peaks are seen
at about 2.5 minutes, which is where the
expected size range is for properly formed
tNLPs. Particles that elute before 2.0 minutes
are considered aggregates or void volume.
A.) The first two graphs represent the tNLPs
that were made by Method #3, variation #1. Is
a variation where curcumin telo-disc were
combined with ApoA1 protein and sonicated
for 30 minutes before overnight incubation.
B.) The last two graphs represent the tNLPs
that were made by Method #3,variation #2.
Here, the curcumin telo-disc was combined
with ApoA1 protein and sonicated for 30
minutes before overnight incubation. The next
morning, more curcumin was added.

Findings and future directions

We managed to create curcumin nano-lipid particles by using three different methods; curcumin telodisc, cell-free curcumin tNLPs, and in-vitro curcumin tNLPs. We showed through both affinity purification
and size-exclusion chromatography (SEC) that the homogenous curcumin-tNLPs form with both cell-free
and in-vitro methods.
The Next Steps:
1. Quantify the amount of curcumin and protein that is in each tNLP.
2. Find the maximum loading capacity of the curcumin-tNLPs.
3. Finally take the tNLPs and test on cell cultures and animal models.
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